BIOBANKING EQUIPMENT MARKET ANALYSIS

Biobanking Equipment Market, By Product (Equipment, Consumables, Software, and Services), By Sample Type (Blood Products, Human Tissues, Umbilical cord blood stem cells, DNA, and Cell Lines), By Application (Regenerative Medicine, Drug Discovery & Clinical Research, and Diagnostics), By End User (Pharmaceutical Companies, Biobanks, Hospitals, and Contract Research Organizations), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Biobanking Equipment Market Regional Insights:

North America is expected to be the largest market for biobanking equipment market during the forecast period, accounting for over 47% of the market share in 2023. The market growth in North America is due to increasing product launches.
The Europe market is expected to be the second-largest market for biobanking equipment market, accounting for over 27.3% of the market share in 2023. The market growth in Europe is due to increasing inorganic strategies by the market players.
The Asia Pacific market is expected to be the fastest-growing market for biobanking equipment market, with a CAGR of over 6.1 % during the forecast period. The market growth in Asia Pacific is due to increasing prevalence of hepatitis C in the region.

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa